Skip to main content
Cerebral Cortex (New York, NY) logoLink to Cerebral Cortex (New York, NY)
. 2017 Oct 13;28(11):3951–3964. doi: 10.1093/cercor/bhx258

Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice

Teresa H Wen 1,2, Sonia Afroz 1, Sarah M Reinhard 3, Arnold R Palacios 1, Kendal Tapia 1, Devin K Binder 1, Khaleel A Razak 2,3,, Iryna M Ethell 1,2,
PMCID: PMC6188540  PMID: 29040407

Abstract

Abnormal sensory responses associated with Fragile X Syndrome (FXS) and autism spectrum disorders include hypersensitivity and impaired habituation to repeated stimuli. Similar sensory deficits are also observed in adult Fmr1 knock-out (KO) mice and are reversed by genetic deletion of Matrix Metalloproteinase-9 (MMP-9) through yet unknown mechanisms. Here we present new evidence that impaired development of parvalbumin (PV)-expressing inhibitory interneurons may underlie hyper-responsiveness in auditory cortex of Fmr1 KO mice via MMP-9-dependent regulation of perineuronal nets (PNNs). First, we found that PV cell development and PNN formation around GABAergic interneurons were impaired in developing auditory cortex of Fmr1 KO mice. Second, MMP-9 levels were elevated in P12−P18 auditory cortex of Fmr1 KO mice and genetic reduction of MMP-9 to WT levels restored the formation of PNNs around PV cells. Third, in vivo single-unit recordings from auditory cortex neurons showed enhanced spontaneous and sound-driven responses in developing Fmr1 KO mice, which were normalized following genetic reduction of MMP-9. These findings indicate that elevated MMP-9 levels contribute to the development of sensory hypersensitivity by influencing formation of PNNs around PV interneurons suggesting MMP-9 as a new therapeutic target to reduce sensory deficits in FXS and potentially other autism spectrum disorders.

Keywords: autism, cortical plasticity, extracellular matrix, fragile X syndrome, sensory hypersensitivity

Introduction

Fragile X Syndrome (FXS) is a leading genetic cause of autism (Crawford et al. 2001). FXS is associated with a CGG trinucleotide repeat expansion in the Fragile X mental retardation (Fmr1) gene that leads to hypermethylation and loss of Fragile X mental retardation protein (FMRP; Yu et al. 1991). FMRP is an mRNA binding protein that regulates synaptic functions through protein translation (Darnell et al. 2011). Humans with FXS display cognitive and communication deficits, as well as delayed language development (Largo and Schinzel 1985; Roberts et al. 2001), hyperarousal (Miller et al. 1999), abnormal social interactions (Hagerman et al. 2009), sensory hypersensitivity and seizures (Wisniewski et al. 1991; Musumeci et al. 1999; Sabaratnam et al. 2001; Berry-Kravis 2002). The Fmr1 knock-out (KO) mice display the core deficits of FXS, including sensory hypersensitivity and abnormal cortical processing (Chen and Toth 2001; Gibson et al. 2008; McNaughton et al. 2008; Pietropaolo et al. 2011; Rotschafer and Razak 2013; Lovelace et al. 2016).

Altered excitatory/inhibitory (E/I) balance may underlie abnormal cortical responses in humans with FXS and Fmr1 KO mice, such as reduced habituation (Castrén et al. 2003; Ethridge et al. 2016; Lovelace et al. 2016; Wang et al. 2017), hyper-responsiveness, broader receptive fields (Rotschafer and Razak 2013; Arnett et al. 2014; Zhang et al. 2014) and increased network synchronization (Paluszkiewicz et al. 2011; Gonçalves et al. 2013; La Fata et al. 2014). However, the cell- and network-specific changes underlying the E/I imbalance are only beginning to be understood (Gibson et al. 2008; reviewed in Contractor et al. 2015).

Normal development of fast-spiking parvalbumin (PV)-positive inhibitory interneurons is implicated in shaping “critical period” plasticity, stabilization of synaptic networks and network synchronization (Hensch 2005; Jeevakumar and Kroener 2016). In the somatosensory cortex of Fmr1 KO mice, there is decreased excitatory drive onto PV neurons and reduced PV expression (Selby et al. 2007; Gibson et al. 2008). Moreover, there is a down-regulation of GABAA receptor subunit α1 during postnatal cortical development in Fmr1 KO mice (Adusei et al. 2010), a subunit normally enriched at PV cell/pyramidal cell synapses. Although these studies implicate PV cell dysfunctions in FXS-associated cortical hyperexcitability, the underlying mechanisms remain unclear.

Perineuronal nets (PNNs), which are extracellular matrix (ECM) components, are often associated with PV cells and regulate their development and functions. Loss of PNNs around PV cells is associated with abnormal critical period plasticity and reduced excitability of PV cells (Pizzorusso et al. 2002; Balmer 2016; Lensjø et al. 2017). PNNs also protect PV cells against oxidative stress (Cabungcal et al. 2013). Matrix Metalloproteinase-9 (MMP-9) is a secreted endopeptidase, which regulates PNN formation and organization by cleaving ECM components (Ethell and Ethell 2007). FMRP negatively regulates MMP-9 translation (Dziembowska et al. 2013) and MMP-9 levels are elevated in FXS (Bilousova et al. 2009; Gkogkas et al. 2014; Sidhu et al. 2014). MMP-9 deletion reverses several FXS phenotypes in Fmr1 KO mice (Sidhu et al. 2014), including impaired auditory response habituation (Lovelace et al. 2016). However, it is unclear how enhanced MMP-9 activity may lead to auditory processing deficits in FXS.

Here, we hypothesized that increased MMP-9 levels affect auditory responses by influencing development of PNNs around PV cells in the auditory cortex of Fmr1 KO mice. We found delayed development of PNNs and PV cells in layer 4 auditory cortex of Fmr1 KO mice. PNN formation was selectively impaired around GABAergic PV interneurons but not excitatory neurons during the same period. In vivo single neuron recordings showed increased responses to tones in Fmr1 KO mouse auditory cortex compared to WT mice at P21 suggesting impaired inhibition. While MMP-9 levels were reduced in the auditory cortex of WT mice after onset of hearing, MMP-9 levels remained elevated in developing auditory cortex of Fmr1 KO mice at P12-18. Genetic reduction of MMP-9 levels restored auditory responses and the formation of PNNs around PV cells in the P21 Fmr1 KO mice to WT levels. The concomitant changes in PV/PNN expression and electrophysiological responses following genetic reduction of MMP-9 in the Fmr1 KO mice strongly suggest that elevated MMP-9 levels contribute to the development of auditory processing deficits by influencing the development of PNNs and PV cells in the auditory cortex of Fmr1 KO mice.

Materials and Methods

Mice

FVB.Cg−Mmp−9tm1Tvu/J, FVB.129P2−Fmr1tm1Cgr/J (Fmr1 KO) and FVB.129P2−Pde6b+Tyrc-ch/AntJ controls (WT) mice were obtained from Jackson laboratories and housed in an accredited vivarium on a 12 h light/dark cycle. Food and water were provided ad libitum. The FVB.Cg−Mmp−9tm1Tvu/J mice were backcrossed, in-house, with Fmr1 KO mice to generate Mmp9 +/−Fmr1 KO mice, which had only 1 allele of the Mmp9 gene and reduced expression of MMP-9. Genotypes were confirmed by PCR analysis of genomic DNA isolated from mouse tails. All procedures were approved by the Institutional Animal Care and Use Committee at the University of California, Riverside and carried out in accordance with NIH “Guide for the Care and Use of Laboratory Animals”.

Immunohistochemistry and Image Analysis

Age-matched male WT, Fmr1 KO, and Mmp9+/−Fmr1 KO mice at ages P14–15, P21–22, and P30–31 were euthanized with sodium pentobarbital or isoflurane and perfused transcardially with cold phosphate-buffered saline (PBS, 0.1 M) and 4% paraformaldehyde (PFA). Mmp9 +/− Fmr1 KO brain samples were collected and analyzed together with experimentally matched WT and Fmr1 KO groups. Brains were removed and post-fixed for 2–4 h in 4% PFA. 100 μm sections were obtained using a vibratome (Leica S1000 or EMS 5000) with a speed of 2–2.5 and amplitude of 6–6.5. Auditory cortex was identified using hippocampal landmarks. This method has been previously validated using tonotopic mapping and dye injection (Martin del Campo et al. 2012) and comparison with the Paxinos mouse atlas and other publications on mouse auditory cortex (Anderson et al. 2009). Nevertheless, the precise boundary between primary auditory cortex (A1) and anterior auditory field (AAF) of the mouse auditory cortex cannot be clearly established. Both these fields are part of the lemniscal auditory system and comprise the core auditory cortex. Therefore, we use the phrase “auditory cortex” to indicate both A1 and AAF.

For each brain, an average of 5–6 slices containing auditory cortex were obtained. Sections were labeled using the following immunohistochemistry protocol. Briefly, brain slices were post-fixed for an additional 2 h in 4% PFA in 0.1 M PBS and then washed in 0.1 M PBS. Slices were then quenched with 50 mM ammonium chloride for 15 minutes and washed with PBS. Next, brain tissues were permeabilized with 0.1% Triton X-100 in PBS and nonspecific staining was blocked with a 5% Normal Goat Serum (NGS; Sigma, catalog# G9023-10 mL) and 1% Bovine Serum Albumin (BSA; Fisher Scientific, catalog# 9 048468) in 0.1 M PBS solution. Slices were then incubated for 24 h with primary antibodies and fluorescein-tagged “Wisteria floribunda agglutinin” (WFA) in 0.1 M PBS containing 1% NGS, 0.5% BSA, and 0.1% Tween-20 solution. WFA (4 μg/mL; Vector Laboratories, cat# FL-1351, RRID:AB_2 336875) is a lectin, which binds glycosaminoglycan side chains of chondroitin sulfate proteoglycans found in PNNs (Pizzorusso et al. 2002). Primary antibodies used include rabbit anti-PV (1:5000; SWANT, catalog# PV25, RRID:AB_10 000344) or mouse anti-PV (1:1000; Sigma, catalog# P3088, RRID:AB_477 329) to label PV interneurons and rabbit anti-GAD65/67 (42.4 μg/mL, Abcam, catalog#ab49832, RRID:AB_880 149) to label all inhibitory interneurons. After incubation with primary antibodies and WFA, slices were washed in 0.1 M PBS containing 0.5% Tween-20 and incubated with secondary antibodies in 0.1 M PBS for 1 h. Secondary antibodies were donkey anti-rabbit Alexa 594 (4 μg/mL; Thermo Fisher Scientific, catalog# A-21 207, RRID:AB_141 637), donkey anti-rabbit Alexa 647 (4 μg/mL; Thermo Fisher Scientific, catalog# A-31 573, RRID:AB_2 536183) and donkey anti-mouse Alexa 594 (4 μg/mL; Thermo Fisher Scientific, catalog# A-21203, RRID:AB_2 535789). Slices were then washed with 0.1 M PBS containing 0.5% Tween-20, mounted with Vectashield containing DAPI (Vector Labs, catalog# H-1200) and Cytoseal (ThermoScientific, catalog# 8310–16). Slices were imaged by confocal microscopy (model LSM 510, Carl Zeiss MicroImaging or Leica SP5) using a series of 20 high-resolution optical sections (1024 × 1024-pixel format) that were captured for each slice using a 10×, 20×, or a 63× water-immersion objective (1.2 numerical aperture), with 1× or 5× zoom at 1 um step intervals (z-stack). All images were acquired under identical conditions. Each z-stack was collapsed into a single image by projection (LSM Image Browser, Zeiss or Image J), converted to a TIFF file, encoded for blind analysis, and analyzed using Image J. Image J was also used to identify and count PNN-positive cells, PV-positive cells, GAD positive cells and colocalization. Cortical layers were identified (Anderson et al. 2009) and used for layer-specific counts. Cell counts were obtained in layers 1–5 of auditory cortex. The freehand selection tool and measure function was used to specify layers of the auditory cortex and the point tool was used to label PNNs, PV cells, and GAD cells added to the ROI manager. Particle Analysis Cell Counter plugin in Image J was used to count colocalization. Two-way ANOVA was used to determine age and genotype differences. To characterize genotype differences, 1-way ANOVA was used with Bonferroni post hoc analysis for normally distributed data. Kruskal–Wallis 1-way analysis of ranks was used with Dunnett’s C for post hoc analysis if data were not normally distributed. Statistical analyses were performed using GraphPad Prism 6.

Gelatin Zymography

P3, P7, P12, and P18 mice (n = 3–7 mice per group) were euthanized with isoflurane and the auditory cortex was dissected based on coordinates (Paxinos and Franklin 2004) and previous electrophysiological and dye-placement studies (Martin del Campo et al. 2012). The tissue samples were flash-frozen on dry ice and stored at −80 °C. Gelatin gel zymography was performed as previously described with minor modifications (Sidhu et al. 2014). Briefly, auditory cortex tissue was re-suspended in 100 μL of 100 mM Tris-HCl (pH = 7.6) buffer containing 150 mM NaCl, 5 mM CaCl2, 0.05% Brij35, 0.02% Na3N, 1% Triton X-100, 100 μM PMSF and PI cocktail (Sigma, catalog# P8340). Lysates were measured for total protein concentrations using the protocol for the BCA colorimetric protein assay (Pierce, 23 235). The gelatinases, MMP-2 and MMP-9, were pulled down with gelatin agarose beads (Sigma, catalog# G5384) and separated on 10% Tris-Glycine gel with 0.1% gelatin as the substrate (Life Technologies). Following separation, gels were soaked in renaturing buffer (Life Technologies, catalog# LC2670) to remove all traces of SDS and allow the MMPs to refold thus regaining their enzymatic activity. Following renaturing, gels were incubated in developing buffer (Life Technologies, catalog# LC2671) for 96 h, allowing the gelatinases (MMP-2 and MMP-9) to degrade the gelatin in the gel. Gels were then stained with Coomassie Blue overnight to uniformly stain the gels after which de-staining revealed areas of MMP activity as unstained bands. Levels of MMP-2 and MMP-9 proteins were quantified by densitometry using Image J. For the analysis of developmental changes in MMP-2 and MMP-9 levels in P3, P7, P12 and P18 WT and Fmr1 KO groups all values were normalized to P7 WT value on the same gel. For the analysis of MMP-2 and MMP-9 levels in MMP-9 +/−Fmr1 KO samples and experimentally matched WT and Fmr1 KO groups, values for MMP-9 +/−Fmr1 KO and Fmr1 KO samples were normalized against values for WT samples with similar protein concentration on the same gel. Statistical analysis was performed using ANOVA for comparison between the groups followed by Bonferroni post hoc pair-by-pair comparisons.

In Vivo Extracellular Electrophysiology

Single-unit recordings were obtained and analyzed using previously published methods to study adult mouse cortical responses (Rotschafer and Razak 2013). Here age-matched (P13–16 and P19–23) male WT, Fmr1 KO, Mmp9 +/−Fmr1 mice were anesthetized with a combination of 1 g/kg urethane and 20 mg/kg xylazine. Toe pinch reflex was monitored to ensure sufficient anesthesia levels and maintained with supplemental doses of urethane and xylazine. When mice were anesthetized, a midline incision was made to expose the skull. The temporalis muscle was reflected and a dental drill was used to create a cranial window to auditory cortex, which was identified using coordinates and vasculature.

Sounds were presented through free field speakers (Player BL Light; Avisoft, Gleinicke, Germany) maintained 7 inches and 45° from the left ear. Single-unit extracellular electrophysiological recordings were obtained from the right auditory cortex (200–700 um depth). While neural activity was recorded from all layers of auditory cortex, the majority of neurons were located in superficial layers (200–450 um; P14:62.5% of WT neurons, 73% of Fmr1 KO neurons; P21:55.68% of WT neurons, 69.23% of KO neurons, and 69.81% of Mmp9+/− neurons) and the distribution of neuron depths did not differ between WT and KO at P14, and WT, KO, and Mmp9 +/− Fmr1 KO mice at P21 (P = n.s.; Chi-square: Depth × Genotype). Tonotopy, short latency responses to pure tone stimuli, and vascular landmarks were used to find neurons in core auditory cortex. The frequency response of the sound delivery system, assessed with a 1 inch Bruel and Kjaer microphone and measuring amplifier, was flat within ± 4 dB between 5 and 40 kHz. The high frequency roll off was ~20 dB from 40–60 kHz. Acoustic stimulation and data acquisition were done with custom written software (Batlab; Dr. Dan Gans, Kent State University) and a Microstar digital processing board. Sound level was controlled using programmable attenuators (PA5; Tucker-Davis Technologies, Gainesville, FL).

Isolated neurons were probed with pure tones (5 ms rise/fall time) in 1 or 5 kHz increments. Tones used were between 4 and 50 kHz as most neurons in the mouse core auditory cortex are tuned to <50 kHz (Rotschafer and Razak 2013). Sound level was changed with 5 dB resolution to determine the characteristic frequency (CF), defined as the frequency at which a neuron responds at a minimum sound level. A tone at a specific frequency and level was counted as being excitatory if the neuron responded to at least 3 out 5 presentations. Response magnitude was compared in WT, Fmr1 KO, and Mmp9 +/−Fmr1 neurons by generating a post-stimulus time histogram of responses to a 50 ms pure tone at the CF presented 15 dB above threshold (20 repetitions, 1 Hz repetition rate, 200 ms recording window from stimulus onset). Spontaneous activity was also recorded within 200 ms windows of silence that were interspersed between stimulus trials. The average spontaneous activity was calculated by dividing the total number of spikes recorded in silent windows divided by the number of repetitions of the silent window. At the end of the experiment, mice were euthanized with 125 mg/kg sodium pentobarbital. Statistical analysis was performed using Kruskal–Wallis 1-way analysis of ranks and Dunnett’s C was used for post hoc analysis to characterize genotype differences as data were not normally distributed. To test for genotype and age effects in P14 and P21 response magnitudes, 2-way ANOVA with Bonferroni post hoc test was used.

Results

PV Cell Development is Impaired in the Developing Auditory Cortex of Fmr1 KO Mice

The density of PV interneurons was analyzed in layers (L) 1–4 auditory cortex of WT and Fmr1 KO mice at P14, P21 and P30 using immunohistochemistry (Fig. 1AI). A significant developmental increase in PV cell density was observed in both WT and Fmr1 KO auditory cortex at P21 (Table 1; age effect, P < 0.01). However, PV cell density was lower in the developing Fmr1 KO auditory cortex compared to WT (Table 1; genotype effect, P < 0.05). Fluorescently tagged WFA was used to assess the density of PNN-containing cells in L1-4 auditory cortex (Fig. 1AI). Similar to PV cell density, a developmental increase in the density of PNN-enwrapped cells was observed in auditory cortex of Fmr1 KO mice (age effect, P < 0.0001, Table 1). PNN density in Fmr1 KO auditory cortex did not reach WT levels until P30 (Fmr1 KO P14 vs. P30, P < 0.001, Table 1). Although there was a delay in PNN development in Fmr1 KO auditory cortex, overall density of PNN-containing cells was not significantly different between genotypes. In summary, our results demonstrate reduced PV cell density in developing auditory cortex of Fmr1 KO mice, and a delayed developmental increase in both PV and PNN-containing cells in Fmr1 KO auditory cortex.

Figure 1.

Figure 1.

Layer-specific differences in PV cell density and PNN formation in developing WT and Fmr1 KO auditory cortex. (AF) Confocal images show PV immunoreactivity and WFA-positive PNN labeling in WT and Fmr1 KO auditory cortex at P14, P21, and P30. Scale bar, 100 μm. (GI) High magnification confocal images show examples of cells with PV immunoreactivity and WFA-positive PNN labeling in WT and Fmr1 KO auditory cortex at P14, P21, and P30. Scale bar, 50 μm. (JM) Quantitative analysis of the density of PV cells (J), PNN-containing cells (K), PNN-containing PV cells (L) and percent of PNN-containing PV cells (M) in L2/3 and 4 of WT and KO auditory cortex. (J) In P14 Fmr1 KO auditory cortex, there was reduced PV cell density in L2/3 (P14 Fmr1 KO vs. WT, P < 0.0001) and L4 (P14 Fmr1 KO vs. WT P < 0.05). (K) In L4 of auditory cortex, PNN-positive cell density was reduced in P14 Fmr1 KO mice (Fmr1 KO vs. WT, P < 0.0001). (L) The density of PV interneurons enwrapped with PNNs was reduced at P21 in L2/3 (Fmr1 KO vs. WT; P < 0.01) and L4 (Fmr1 KO vs. WT; P < 0.0001) of Fmr1 KO auditory cortex as compared to WT. (M) The percent of PV cells containing PNNs was also reduced in L4 of Fmr1 KO auditory cortex as compared to WT at P21 (Fmr1 KO vs. WT; P < 0.01). Statistical analysis was performed using 2-way ANOVA with Bonferroni’s multiple comparisons post-test (WT N: P14 3 animals/20 slices; P21 7/43; P30 8/59. Fmr1 KO N: P14 3/22; P21 6/45; P30 7/66; *P < 0.05; **P < 0.01; ****P < 0.0001).

Table 1.

PV cell development and PNN formation in the auditory cortex of WT and Fmr1 KO mice

AGE WT KO
PV + cell density PNN + cell density PV + cell density PNN + cell density
P14 76.71 ± 4.39 43.55 ± 9.14 53.07 ± 5.07 24.05 ± 7.91
P21 103.42 ± 11.12 59.92 ± 7.21 89.22 ± 5.31 51.71 ± 5.66
P30 92.20 ± 5.86 66.80 ± 6.46 83.00 ± 6.04 83.24 ± 5.18

PV+ and PNN+ cell density in layers 1–4 of WT and KO auditory cortex (average ± SEM). Two-way ANOVA. PV cell density: genotype effect P = 0.0317; age effect P = 0.0028. PNN cell density: genotype effect P = n.s.; age effect P < 0.0001 (Bonferroni post hoc test: Fmr1 KO P14 vs. P30, P < 0.001; Fmr1 KO P21 vs. P30, P < 0.05). WT N: P14 3 animals/20 slices; P21 7/43; P30 8/59; P60 5/43. KO N: P14 3/22; P21 6/45; P30 7/66.

PNN Formation is Selectively Impaired Around PV Interneurons in Fmr1 KO Auditory Cortex at P21

Given a prominent accumulation of PNNs in L4 of sensory cortices and their abundance around PV cells in the adult cortex (Pizzorusso et al. 2002; Brewton et al. 2016), we next characterized layer-specific PV and PNN cell density in WT and Fmr1 KO auditory cortex at P14, P21, and P30. PV cell density was lower in L4 Fmr1 KO auditory cortex compared to WT at all ages (genotype effect, P < 0.05; Fig. 1J). The difference was most prominent at P14, when we observed a significant reduction in PV cell density in both L2/3 and L4 Fmr1 KO auditory cortex compared to WT (L2/3, P < 0.0001; L4, P < 0.05; Fig. 1J). However, a developmental increase in PV cell density was only detected in L4 but not L2/3 of WT auditory cortex (WT, P14 vs P21, P < 0.01; Fig. 1J). In addition, a developmental delay in PNN cell density was specifically observed in L4 Fmr1 KO auditory cortex. PNN density was lower in L4 Fmr1 KO auditory cortex compared to WT mice at P14 (P < 0.0001) and did not reach WT levels until P30 (Fig. 1K).

To determine if PNN formation was impaired around PV neurons, we analyzed the density of PNN/PV double-labeled cells and the percentage of PV cells containing PNN. We found that at P21 PNN formation was selectively impaired around PV cells in Fmr1 KO auditory cortex compared to WT in both L2/3 (P < 0.01) and L4 (P < 0.0001; Fig. 1L). The percentage of PNN-containing PV cells was also reduced in L4 Fmr1 KO auditory cortex compared to WT at P21 (P < 0.01, Fig. 1M). Taken together, these data demonstrate developmental delays in PNN formation in L4 Fmr1 KO auditory cortex, which can potentially affect PV expression and functions.

Reduced PNN Formation Around GABAergic Interneurons in L4 Fmr1 KO Auditory Cortex at P21

We next examined whether the reduction in PNN formation in L4 Fmr1 KO auditory cortex was specific to GABAergic interneurons or if PNN formation was also impaired around non-GABAergic cells (Fig. 2A). A significant decrease in the density of GABAergic interneurons with PNNs was observed in Fmr1 KO auditory cortex compared to WT at P21 (Fig. 2B; WT vs. Fmr1 KO, P < 0.01). While PNN labeling was also detected around GAD65/67 negative cells (presumably excitatory neurons; arrowheads in Fig. 2C,D), there were no genotype differences in the density of PNN-containing cells lacking GAD65/67, indicating that impaired PNN formation was specific to GABAergic interneurons at P21. By P30 we no longer observed the differences in the density of PNN-containing GABAergic interneurons between WT and Fmr1 KO auditory cortex (Fig. 2B). Taken together, these results show a delayed development of PNNs around GABAergic interneurons in L4 Fmr1 KO auditory cortex specifically at P21, which may lead to abnormal cortical development and underlie auditory processing deficits associated with FXS.

Figure 2.

Figure 2.

PNN formation was selectively impaired around GABAergic interneurons in L4 Fmr1 KO auditory cortex at P21. (A) Confocal low magnification image shows GAD65/67 (red) and PV immunoreactivity (blue), and WFA-positive PNN labeling (green) in WT auditory cortex. Scale bar, 100 μm. (B) Quantitative analysis of the density of PNN-positive GABAergic (GAD65/67 positive) and excitatory (GAD65/67 negative) neurons in L4 of WT and Fmr1 KO auditory cortex at P21 and P30. (Top) Fmr1 KO mice showed reduced density of GABAergic interneurons enwrapped with PNNs in L4 auditory cortex as compared to WT at P21 (**P < 0.01). (Bottom) There was a developmental increase in GAD-negative cells enwrapped with PNNs (P21 vs. P30; **P < 0.01), but there were no genotype-specific differences. Statistical analysis was performed using 2-way ANOVA with Bonferroni multiple comparisons post-test (WT N: P21 3 animals/12 slices; P30 3/26. Fmr1 KO N: P21 3/20; P30 3/12). (C, D) Confocal high magnification images of net structures exemplifying PNNs that surround PV, GAD+ and GAD- cells in WT and Fmr1 KO auditory cortex at P21 (C) and P30 (D). Scale Bar, 100 μm. White star indicates a GAD+/PV+ cell (purple) without PNN, arrows indicate GAD+/PV+ cells with PNN, arrowheads indicate GAD-/PV- cells with PNNs.

MMP-9 Levels are Higher in the Developing Auditory Cortex of Fmr1 KO Mice

MMP-9 cleaves ECM and PNNs (Ethell and Ethell 2007; Reinhard et al. 2015) and is elevated in FXS human brain and Fmr1 KO mouse hippocampus (Dziembowska et al. 2013; Sidhu et al. 2014; Gkogkas et al. 2014), which may affect PNN development. Therefore, we first examined whether MMP-9 levels are elevated in developing auditory cortex of WT and Fmr1 KO mice using a gelatin zymography assay. MMP-9 levels peaked in WT auditory cortex at P7 (Fig. 3A,B) just prior to hearing onset (Ehret 1976; Kraus and Aulbach-Kraus 1981). In WT auditory cortex, MMP-9 levels decreased at P12 and remained low at P18 (Fig. 3A,B; effect of age P < 0.001), during the period of active PNN formation around PV cells and maturation of auditory cortex. While MMP-2 levels were not different between genotypes, MMP-9 levels were consistently elevated in Fmr1 KO as compared to WT at all ages (P < 0.01; Fig. 3AC), suggesting that enhanced MMP-9 activity may impede PNN formation around PV interneurons in developing auditory cortex of Fmr1 KO mice.

Figure 3.

Figure 3.

Detection of MMP-9 and MMP-2 levels in the developing auditory cortex. (A, D) Detection of MMP-9 and MMP-2 levels using gelatin zymography. (B, C) Graph shows MMP-9 (B) and MMP-2 (C) levels in WT and Fmr1 KO auditory cortex at P3, P7, P12 and P18 (values were quantified by densitometry and normalized to the P7 WT value). (B) Levels of MMP-9 peak at P7 and decrease with age during auditory cortex development in WT mice; however compared to WT levels MMP-9 levels are elevated in Fmr1 KO mice at all ages (P < 0.01). (C) MMP-2 levels also showed a developmental down-regulation from P3 to P18 (Fig. 4C; P < 0.05) but levels were similar between WT and Fmr1 KO mice at all ages (Fig. 4C; P = n.s.). Statistical analysis was performed using 2-way ANOVA with Bonferroni’s multiple comparisons post-test (WT N: 6, 8, 4, and 4 mice. Fmr1 KO N: 6, 8, 4, and 4 mice). (E, F) Graph shows MMP-9 (E) and MMP-2 (F) levels in WT, Fmr1 KO and MMP-9 +/−Fmr1 KO auditory cortex at P12 (values for MMP-9 +/−Fmr1 KO and Fmr1 KO samples were normalized against values for WT sample with similar protein concentration run on the same gel). Levels of MMP-9 were significantly higher in Fmr1 KO (*P < 0.05) but not MMP-9 +/−Fmr1 KO auditory cortex as compared to WT, whereas MMP-9 levels were significantly lower in MMP-9 +/−Fmr1 KO auditory cortex as compared to Fmr1 KO (**P < 0.01). Statistical analysis was performed using 1-way ANOVA with Bonferroni multiple comparisons post-test (WT N: 9 mice, Fmr1 KO N: 9 mice and MMP-9 +/−Fmr1 KO N: 6 mice).

MMP-9 Reduction Promotes PNN Formation Around PV Interneurons in Layer 4 of Fmr1 KO Auditory Cortex

To determine whether elevated MMP-9 levels contribute to abnormal PNN and PV cell development in Fmr1 KO auditory cortex, we examined the effects of genetic reduction of MMP-9 on PV/PNN expression (Fig. 4AC). At P12, MMP-9 levels were found to be significantly higher in Fmr1 KO as compared to WT (P < 0.05) and MMP-9 +/−Fmr1 KO (P < 0.01, Fig. 3D,E), and were restored to WT levels in Mmp9 +/−Fmr1 KO auditory cortex. While genetic reduction of MMP-9 levels did not affect the density of PV cells in Mmp9 +/−Fmr1 KO mice as compared to experimentally matched Fmr1 KO mice (Fig. 4D), PNN density was significantly higher in layer 4 of Mmp9 +/−Fmr1 KO auditory cortex than in Fmr1 KO at P21 (P < 0.0001; Fig. 4E), even exceeding WT levels (P < 0.01; Fig. 4E). The density of PV cells with PNN was also significantly higher in Mmp9 +/−Fmr1 KO auditory cortex compared to Fmr1 KO at P21 (P < 0.01; Fig. 4F). Moreover, the percentage of PV cells containing PNN was restored to WT levels in layer 4 of Mmp9 +/−Fmr1 KO auditory cortex at P21 and was significantly higher than in Fmr1 KO (P < 0.001; Fig. 4G). In contrast, we found no differences in the density of PV cells, PV cells with PNN, and the percentage of PV cells with PNNs in layer 5 of WT, Fmr1 KO, and Mmp9 +/−Fmr1 KO auditory cortex (Supplementary Fig. 1). These findings strongly suggest that abnormally high MMP-9 levels in the developing Fmr1 KO mouse auditory cortex may primarily affect PNN formation around GABAergic PV interneurons in layer 4, which in turn may lead to reduced inhibition in the cortical network.

Figure 4.

Figure 4.

Genetic MMP-9 reduction promotes PNN formation around PV interneurons in L4 Fmr1 KO auditory cortex at P21. (AC) Confocal images of PV (red) and WFA-positive PNN-containing (green) cells in L4 auditory cortex of WT, Fmr1 KO, and Mmp9 +/−Fmr1 KO mice at P21. Mmp9 +/− Fmr1 KO brain samples were collected and analyzed together with experimentally matched WT and KO groups. Scale Bar, 100 μm. White * indicates a PV cell without PNN, white arrows indicate PV cells with PNN. (D-G) Quantitative analysis of the density of PV cells (D), PNN-containing cells (E), PNN/PV expressing cells (F) and percent of PNN-containing PV cells (G) in L4 auditory cortex of WT, Fmr1 KO, and Mmp9 +/−Fmr1 KO at P21. (D) PV cell density was reduced in Fmr1 KO auditory cortex as compared to WT (Fmr1 KO vs. WT **P < 0.01). (E) PNN cell density was reduced in Fmr1 KO mice (*P < 0.05) but was significantly higher in Mmp9 +/−Fmr1 KO mice compared to KO (****P < 0.001). (F) PNN/PV cell density was reduced in Fmr1 KO compared to WT cortex (****P < 0.0001), but was significantly higher in Mmp9 +/−Fmr1 KO compared to KO (**P < 0.01). (G) Fmr1 KO mice showed reduced percentage of PV cells with PNNs but not after MMP-9 reduction in Mmp9 +/−Fmr1 KO mice (WT vs. Fmr1 KO, ****P < 0.0001; Mmp9 +/−Fmr1 KO vs. Fmr1 KO, ***P < 0.01). Statistical analysis was performed using 1-way ANOVA with Bonferroni’s multiple comparisons post-test, and Kruskal–Wallis 1-way analysis of ranks for data which was not normally distributed (WT N: P21 3 animals/22 slices; Fmr1 KO N: P21 3/17; Mmp9 +/−Fmr1 KO N: P21 3/24).

Response Magnitudes are Increased in Developing Auditory Cortex of Fmr1 KO Mice

As the maturation of the synaptic and intrinsic properties of the mouse auditory cortex neurons occurs during the P12–P21 window (Oswald and Reyes 2011; Kim et al. 2013) and PNN disruption is known to reduce PV cell excitability and to affect excitatory/inhibitory balance in sensory cortex (Balmer 2016; Lensjø et al. 2017), we hypothesized that in vivo responses of developing auditory cortical neurons to sounds will be also shifted towards more excitation in Fmr1 KO mice. The magnitude of pure tone-evoked responses was compared between WT and Fmr1 KO at P13–16 (P14 group) and P19–23 (P21 group), as deficits in PV expression were observed at P14, and reduced PV and PNN colocalization was prominent at P21 (Figs 1 and 4). Figure 5A and D shows example PSTHs in response to a 50 ms CF tone in WT and Fmr1 KO neurons at P14 and P21, respectively. At P14, response magnitude was not different between WT and KO mice (Fig. 5BE). However, at P21, Fmr1 KO mice showed increased response magnitude across the entire 200 ms recording window compared to WT, as seen previously in adults (Rotschafer and Razak 2013; Fmr1 KO vs. WT, P < 0.01; Fig. 5E). When the recording window was split between the first 50 ms onset response and the 51–200 ms ongoing response, it was evident that differences were more influenced by changes in the ongoing response (Fig. 5B,C). Fmr1 KO mice also exhibited age-related increase in spontaneous activity from P14 to P21 and more spontaneous activity in P21 Fmr1 KO auditory cortex compared to WT (Fmr1 KO mice P14− > P21 P < 0.01, Fmr1 KO vs. WT, P < 0.0001; Fig 5F). These data indicate that responses become abnormally high between P14 and P21 Fmr1 KO auditory cortex, a time window during which the PNNs mature around PV interneurons.

Figure 5.

Figure 5.

Response magnitudes and spontaneous activity are enhanced in P21 Fmr1 KO auditory cortex. (A, D) PSTHs showing example responses within 200 ms from the onset of a 50 ms pure tone stimulus (black bar) played at the CF, 15 dB above threshold in a WT (top) and a Fmr1 KO neuron (bottom) at P14 (A) or P21 (D). (B, C) Analysis shows increased spikes/stimulus in the ongoing response (C) but not the first 50 ms onset response (B) in Fmr1 KO auditory cortex as compared to WT at P21 but not P14 (P21 WT vs. Fmr1 KO, **P < 0.01). Additionally, response magnitude increases in Fmr1 KO auditory cortex with age but not in WT (Fmr1 KO P14− > P21, P < 0.001). (E) Genotype and age differences at P21 were also evident when the response magnitude was measured across the entire 200 ms recording window (P21 WT vs. Fmr1 KO, **P < 0.01; Fmr1 KO P14− > P21, **P < 0.01). (F) Spontaneous activity was also significantly higher in Fmr1 KO auditory cortex at P21 but not P14. Statistical analysis was performed using 2-way ANOVA with Bonferroni’s multiple comparisons post-test. (For response magnitude, P14 WT N = 73 neurons, KO N = 85 neurons; P21 WT N = 89 neurons, KO N = 92 neurons. For spontaneous activity, P14 WT N = 67, KO N = 83; P21 WT N = 88 neurons, KO N = 91 neurons; **P < 0.01, ***P < 0.001, ****P < 0.0001).

Genetic Reduction of MMP-9 Restores Auditory Cortex Response Magnitudes in Fmr1 KO Neurons to WT Levels

Given that PNN formation around PV cells was restored to WT levels following genetic reduction of MMP-9 in Fmr1 KO mice at P21, we examined if single-unit responses were also restored in auditory cortex of Mmp9 +/−Fmr1 KO mice. In order to test this, the magnitude of pure tone-evoked responses was compared between WT, Fmr1 KO, and Mmp9 +/−Fmr1 KO neurons from P19–23 auditory cortex neurons. Figure 6A shows example PSTHs in response to a 50 ms CF tone in WT (top), Fmr1 KO (middle), and Mmp9 +/−Fmr1 KO (bottom) neurons. Responses were restored to WT levels with genetic reduction of MMP-9 levels in the Mmp9 +/−Fmr1 KO mice (Fig. 6BD). The spontaneous activity was also significantly higher in the Fmr1 KO mice compared to WT (Fmr1 KO vs. WT, P < 0.0001; Fig. 6E) and was restored to WT levels with MMP-9 reduction (Fmr1 KO vs. Mmp9 +/−Fmr1 KO, P < 0.0001; Fig. 6E). Together, these data show enhanced responses in the Fmr1 KO mice compared to WT, and a restoration of normal responses by genetic reduction of MMP-9 in the Mmp9 +/−Fmr1 KO mice.

Figure 6.

Figure 6.

Genetic reduction of MMP-9 restores response magnitudes in Fmr1 KO mice to WT levels. (A) PSTHs showing example responses within 200 ms from the onset of a 50 ms pure tone stimulus (black bar) played at the CF, 15 dB above threshold in a WT (top), Fmr1 KO (middle), and Mmp9 +/− Fmr1 KO neuron (bottom). (B, C) Graphs show the first 50 ms onset response (B) and the 51–200 ms ongoing response (C). There is increased spikes/stimulus in the ongoing response (C) in Fmr1 KO mice, which is restored to WT levels with genetic reduction of MMP-9 (**P < 0.01 WT vs. Fmr1 KO, ***P < 0.001 Fmr1 KO vs. Mmp9 +/− Fmr1 KO). (D) Across the entire 200 ms recording window, the mean spikes per stimulus presentation, averaged over 20 stimulus presentations, is increased in Fmr1 KO neurons and restored to WT levels with genetic reduction of MMP-9 (WT vs. Fmr1 KO, **P < 0.01; Fmr1 KO vs. Mmp9 +/− Fmr1 KO, ***P < 0.001). (E) Spontaneous activity is increased in Fmr1 KO mice and restored to WT levels with genetic reduction of MMP-9. Statistical analysis was performed using Kruskal–Wallis 1-way analysis of ranks with Dunnett’s C for post hoc analysis (for response magnitude, WT N: 12 animals/89 neurons; Fmr1 KO N: 13 animals/92 neurons; Mmp9 +/− Fmr1 KO N: 12 animals/107 neurons. For spontaneous activity, WT N: 12 animals/88 neurons; Fmr1 KO N: 13 animals/91 neurons; Mmp9 +/− Fmr1 KO N: 12 animals/106 neurons **P < 0.01, ***P < 0.001, ****P < 0.0001)

Discussion

Auditory hypersensitivity is a common symptom in humans with FXS that may be related to abnormal sound evoked responses (Castrén et al. 2003; Van der Molen et al. 2012) and resting state hyperactive networks (Wang et al. 2017). Recent studies in humans with FXS (Ethridge et al. 2016; Wang et al. 2017) showed that abnormalities in sound evoked responses were correlated with heightened sensory sensitivity and autism-associated social impairment (Social Communication Questionnaire). Such symptoms are also prominent in autism spectrum disorders, in general (reviewed in Sinclair et al. 2017). Sensory hypersensitivity may be driven by highly excitable cortical network activity that arises due to abnormal E/I balance (Rubenstein and Merzenich 2003). Our previous studies showed hyperexcitable auditory cortical responses (Rotschafer and Razak 2013) and impaired habituation to repeated sounds in adult Fmr1 KO mice (Lovelace et al. 2016), suggesting impaired E/I balance. We show for the first time that Fmr1 KO mice exhibit delayed development of PV interneurons and impaired PNN formation around PV interneurons in the developing auditory cortex. The deficits in PNN formation are most pronounced at P21 and are seen primarily in GABAergic PV neurons. Elevated MMP-9 levels most likely contribute to the deficits in developing Fmr1 KO auditory cortex, as MMP-9 reduction in Mmp9 +/−Fmr1 KO mice restored PNN formation around PV interneurons and sound evoked and spontaneous activity to WT levels (Fig. 7). These data implicate MMP-9 in the development of auditory cortex hyperexcitability in Fmr1 KO mice via the regulation of PNN formation around PV interneurons and provide further support for targeting MMP-9 in treatment of FXS.

Figure 7.

Figure 7.

Working model of the effects of MMP-9 reduction on PNN formation in auditory cortex of the Fmr1 KO mice. (Left) In WT animals, there is normal production of FMRP, which translationally suppresses MMP-9 production, resulting in normal development and maturation of PV interneurons (white) and PNNs (black) and normal neural excitability. (Middle) Fmr1 KO results in loss of FMRP and upregulated production of MMP-9. High MMP-9 levels lead to the enhanced cleavage and loss of PNNs around PV cells and alters E/I balance. (Right) PNN formation is enhanced around PV cells following genetic reduction of MMP-9 in the Fmr1 KO mice, resulting in normal density of PNN-containing PV cells and reduced excitability in Mmp9 +/−Fmr1 KO auditory cortex as compared to Fmr1 KO mice.

Fast-spiking PV cells are inhibitory interneurons implicated in shaping cortical E/I balance and network oscillatory activity relevant to sensory processing (Sohal et al. 2009; Cardin et al. 2009; Buzsáki and Wang 2012). In our studies, impaired PNN formation around PV interneurons was observed in L2/3 and 4, but not L5 of the developing auditory cortex in Fmr1 KO mice. L4 fast-spiking PV cells receive thalamic inputs (Winer et al. 2005) and provide feed-forward inhibition onto the thalamo-recipient pyramidal cells in L3 and 4 (Schiff and Reyes 2012), which then project to L2/3, where signals are further refined (Douglas and Martin 2004; Winer et al. 2005). PV-mediated inhibition in L2/3 is necessary for sharpening frequency receptive fields and helping to establish contrast of frequency representations (Li et al. 2014; Natan et al. 2015), both of which are impaired in Fmr1 KO mice (Rotschafer and Razak 2013; Kim et al. 2013). Involvement of PV interneurons in abnormal sensory processing in FXS is consistent with reduced excitatory drive onto PV interneurons and reduced PV expression in developing and adult somatosensory cortex of Fmr1 KO mice (Selby et al. 2007; Gibson et al. 2008) and with abnormal resting gamma oscillations in humans with FXS (Wang et al. 2017), suggesting a broader role of PV neuron dysfunction in sensory abnormalities in FXS. These data are also consistent with altered PV cell function in other autism mouse models (Gogolla et al. 2009).

PNNs enwrap both inhibitory and excitatory neurons (Carulli et al. 2006), but we observed a selective loss of PNNs around PV-positive GABAergic interneurons at P21, with no differences observed in PNN expression around PV-negative neurons at P21. In addition to providing structural support (Brückner et al. 2000; Dansie and Ethell 2011; Wlodarczyk et al. 2011), PNNs regulate survival (Morawski et al. 2004, 2015; Cabungcal et al. 2013) and excitability of PV interneurons (Dityatev et al. 2007; Carulli et al. 2010; Balmer 2016), and stabilization of sensory circuits (Pizzorusso et al. 2002; McRae et al. 2007). PNNs also regulate PV cell maturation via internalization of homeoprotein Otx2, which is needed for transcription, normal PV development and critical period plasticity in developing visual cortex (Sugiyama et al. 2008). Chondroitinase ABC, an enzyme that cleaves PNN proteoglycans, reduces GABAA inhibitory postsynaptic currents (Liu et al. 2013) and reduces excitability of PV fast-spiking cortical interneurons (Balmer 2016). Thus the loss of PNN around PV cells may lead to impaired maturation, survival and/or reduced excitability of PV neurons and overall loss of inhibition in the network leading to FXS-related sensory hypersensitivity.

While delayed PNN formation may contribute to enhanced excitability in P21 Fmr1 KO mice, this does not explain impaired PV cell development that occurs during early PNN formation at P14. This early reduction in the number of PV cells may occur due to abnormal interneuron differentiation and migration during embryonic development (Castrén et al. 2005; reviewed in Castrén 2016). FMRP is especially important for normal fate determination of radial glia, known progenitors of both excitatory and inhibitory neurons in the cortex (Tervonen et al. 2009; Saffary and Xie 2011). FMRP may regulate PV cell fate through translational control of transcription factors necessary for GABAergic neuron differentiation (reviewed in Sultan et al. 2013). Although we see reduced PV density in Fmr1 KO auditory cortex at P14, no differences in spontaneous and evoked responses were observed between WT and KO at P14. Auditory hypersensitivity developed between P14 and P21, which coincides with a critical window for E/I balance maturation and PNN formation in the auditory cortex. Therefore, hypersensitive neural circuits are not present around the time of hearing onset in the Fmr1 KO mice, but develop between P14 and P21 suggesting a window for potential treatment of sensory hypersensitivity. Our results also suggest that reduced PV expression alone at P14 do not cause increased response magnitudes in the Fmr1 KO mice, but the abnormal maturation of PNN, likely driven by high MMP-9 levels, drive single-unit hyperexcitability at P21.

The abnormally high MMP-9 levels, altered PV/PNN development and increased responses that we observed in Fmr1 KO auditory cortex occur during a critical window of auditory cortex development in mice. Intrinsic properties of PV inhibitory interneurons undergo major changes during P10–P29 period of early postnatal development. Younger P10–19 PV cells exhibit broader action potentials, longer after-hyperpolarizations, and higher adaptation ratios, resulting in overall reduced firing rates as compared to older P19–29 PV cells. Investigation of synapses between PV and pyramidal neurons also demonstrate age-related reduction of IPSP rise, peak, and decay time between P10–19 and P19–29 (Oswald and Reyes 2011). Fmr1 KO neurons exhibit increased response magnitudes and spontaneous activity and PV/PNN deficits during this developmental window that coincides with the maturation of cortical inhibition. Taken together, these data indicate that increased single neuron hyperexcitability in Fmr1 KO auditory cortex may arise from delayed maturation of PV neurons, which can occur with disruption of PNNs. The lower PV/PNN density and reduced network inhibition during early development is also consistent with altered critical period plasticity observed in the auditory cortex of Fmr1 KO auditory cortex (Kim et al. 2013; Hensch 2005).

Another major finding presented here is that developmental delay in PNN formation in Fmr1 KO auditory cortex may be attributed to elevated MMP-9 levels, as genetic reduction in MMP-9 levels was able to reverse abnormal PNN formation around PV cells and to restore auditory response magnitude at P21. In addition, we found a significant reduction in PV expression and PV/PNN colocalization in MMP-9 −/− mice (not shown), which is consistent with MMP-9 role in neurodevelopment (reviewed in Reinhard et al. 2015), suggesting that too much or too little MMP-9 would affect PV cell development. Therefore, instead of deleting or reducing MMP-9 below the normal levels, in these studies we examined the effects of restoring MMP-9 to WT levels in Fmr1 KO mice. This approach is also closer to our goal of developing future therapeutic approaches to restoring MMP-9 to WT levels in FXS. Excessive MMP proteolytic activity may affect formation of ECM and PNNs by cleaving its link proteins, such as laminin, fibronectin and aggrecan (D’ortho et al. 1997). The role of ECM in cortical plasticity has been previously reported (Pizzorusso et al. 2002; Nagy et al. 2006; McRae et al. 2007; Rivera et al. 2010), but the effects of elevated MMP-9 on cell and network function in FXS are still unclear. MMP-9 levels are elevated in FXS human brains and the hippocampus of Fmr1 KO mice (Dziembowska et al., 2013; Sidhu et al. 2014; Gkogkas et al. 2014). Here we report that MMP-9 levels are also elevated during a developmental sensitive window in Fmr1 KO auditory cortex, whereas genetic reduction of MMP-9 in Fmr1 KO mice rescues observed PNN deficits and restores response magnitudes and spontaneous activity to WT levels. Genetic deletion of MMP-9 rescues several other FXS phenotypes, including improper dendritic spine maturation, enhanced mGluR5-dependent-LTD, abnormal social behavior and macroorchidism (Sidhu et al. 2014). On the other hand, MMP-9 overexpression mimics FXS phenotypes, resulting in immature spine development, social behavior deficits and macroorchidism (Gkogkas et al. 2014). Elevated MMP-9 levels in Fmr1 KO auditory cortex are most likely responsible for the developmental delay in PNN formation around PV cells during auditory cortex development and is at least partially responsible for auditory processing deficits. Our studies provide a novel mechanistic insight into sensory hyper-responsiveness in FXS taking into account early developmental circuit changes and emphasize the importance of MMP-9 and PNNs in normal auditory cortex development.

Supplementary Material

Supplementary Data

Notes

We thank members of the Ethell, Binder and Razak laboratories for helpful discussions. We also thank David Carter for advice on confocal microscopy. Conflict of Interest: The authors declare no competing financial interests.

Funding

This work was supported by the National Institute of Child Health and Human Development and the National Institute of Mental Health (1U54 HD082008-01 to I.M.E., D.K.B., and K.A.R.); U.S. Army Medical Research and Materiel Command (W81XWH-15-1-0436 to I.M.E., D.K.B., and K.A.R.); and the National Science Foundation (to S.R.).

References

  1. Adusei DC, Pacey LK, Chen D, Hampson DR. 2010. Early developmental alterations in GABAergic protein expression in fragile X knockout mice. Neuropharmacology. 59:167–171. [DOI] [PubMed] [Google Scholar]
  2. Anderson LA, Christianson GB, Linden JF. 2009. Mouse auditory cortex differs from visual and somatosensory cortices in the laminar distribution of cytochrome oxidase and acetylcholinesterase. Brain Res. 1252:130–142. [DOI] [PubMed] [Google Scholar]
  3. Arnett MT, Herman DH, McGee AW. 2014. Deficits in tactile learning in a mouse model of fragile X syndrome. PLoS One. 9:e109116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Balmer TS. 2016. Perineuronal nets enhance the excitability of fast-spiking neurons. eNeuro. 3:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berry-Kravis E. 2002. Epilepsy in fragile X syndrome. Dev Med Child Neurol. 44:724–728. [DOI] [PubMed] [Google Scholar]
  6. Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW, Ethell IM. 2009. Minocycline promotes dendritic spine maturation and improves behavioral performance in the fragile X mouse model. J Med Genet. 46:94–102. [DOI] [PubMed] [Google Scholar]
  7. Brewton DH, Kokash J, Jimenez O, Pena ER, Razak KA. 2016. Age-related deterioration of perineuronal nets in the primary auditory cortex of mice. Front Aging Neurosci. 8:270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brückner G, Grosche J, Schmidt S, Härtig W, Margolis RU, Delpech B, Seidenbecher CI, Czaniera R, Schachner M. 2000. Postnatal development of perineuronal nets in wild‐type mice and in a mutant deficient in tenascin‐R. J Comp Neurol. 428:616–629. [DOI] [PubMed] [Google Scholar]
  9. Buzsáki G, Wang XJ. 2012. Mechanisms of gamma oscillations. Annu Rev Neurosci. 35:203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cabungcal JH, Steullet P, Morishita H, Kraftsik R, Cuenod M, Hensch TK, Do KQ. 2013. Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci. 110:9130–9135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, Moore CI. 2009. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 459:663–667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Carulli D, Rhodes KE, Brown DJ, Bonnert TP, Pollack SJ, Oliver K, Strata P, Fawcett JW. 2006. Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol. 494:559–577. [DOI] [PubMed] [Google Scholar]
  13. Carulli D, Pizzorusso T, Kwok JCF, Putignano E, Poli A, Forostyak S, Andrews MR, Deepa SS, Glant TT, Fawcett JW. 2010. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain. 133:2331–2347. [DOI] [PubMed] [Google Scholar]
  14. Castrén M, Pääkkönen A, Tarkka IM, Ryynänen M, Partanen J. 2003. Augmentation of auditory N1 in children with fragile X syndrome. Brain Topogr. 15:165–171. [DOI] [PubMed] [Google Scholar]
  15. Castrén M, Tervonen T, Kärkkäinen V, Heinonen S, Castrén E, Larsson K, Bakker CE, Oostra BA, Akerman K. 2005. Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci USA. 102:17834–17839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Castrén ML. 2016. Cortical neurogenesis in fragile X syndrome. Front Biosci (Scholar edition). 8:160. [DOI] [PubMed] [Google Scholar]
  17. Chen L, Toth M. 2001. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience. 103:1043–1050. [DOI] [PubMed] [Google Scholar]
  18. Contractor A, Klyachko VA, Portera-Cailliau C. 2015. Altered neuronal and circuit excitability in fragile X syndrome. Neuron. 87:699–715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Crawford DC, Acuña JM, Sherman SL. 2001. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med. 3:359–371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. D’ortho M-P, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem. 250:751–757. [DOI] [PubMed] [Google Scholar]
  21. Dansie LE, Ethell IM. 2011. Casting a net on dendritic spines: the extracellular matrix and its receptors. Dev Neurobiol. 71:956–981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Darnell JC, Van Driesche SJ, Zhang C, Hung KYS, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, et al. . 2011. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell.. 146:247–261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Dityatev A, Brückner G, Dityateva G, Grosche J, Kleene R, Schachner M. 2007. Activity-dependent formation and functions of chondroitin sulfate-rich extracellular matrix of perineuronal nets. Dev Neurobiol. 67:570–588. [DOI] [PubMed] [Google Scholar]
  24. Douglas RJ, Martin KAC. 2004. Neuronal circuits of the neocortex. Annu Rev Neurosci. 27:419–451. [DOI] [PubMed] [Google Scholar]
  25. Dziembowska M, Pretto DI, Janusz A, Kaczmarek L, Leigh MJ, Gabriel N, Durbin-Johnson B, Hagerman RJ, Tasson F. 2013. High MMP9 activity levels in fragile X syndrome are lowered by minocycline. Am J Med Genet Part A. 161:1897–1903. [DOI] [PubMed] [Google Scholar]
  26. Ehret G. 1976. Development of absolute auditory thresholds in the house mouse (Mus musculus). Ear Hear. 1:179–184. [PubMed] [Google Scholar]
  27. Ethell IM, Ethell DW. 2007. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res. 85:2813–2823. [DOI] [PubMed] [Google Scholar]
  28. Ethridge LE, White SP, Mosconi MW, Wang J, Byerly MJ, Sweeney JA. 2016. Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome. Transl Psychiatry.. 6:e787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gibson JR, Bartley AF, Hays SA, Huber KM. 2008. Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. J Neurophysiol. 100:2615–2626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gkogkas CG, Khoutorsky A, Cao R, Jafarnejad SM, Prager-Khoutorsky M, Giannakas N, Kaminari A, Fragkouli A, Nader K, Price T, et al. . 2014. Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes. Cell Rep. 9:1742–1755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Gogolla N, Leblanc JJ, Quast KB, Südhof TC, Fagiolini M, Hensch TK. 2009. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord. 1:172–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gonçalves JT, Anstey JE, Golshani P, Portera-Cailliau C. 2013. Circuit level defects in the developing neocortex of Fragile X mice. Nat Neurosci. 16:903–909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootskak J, et al. . 2009. Advances in the treatment of fragile X syndrome. Pediatrics. 123:378–390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hensch TK. 2005. Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 6:877–888. [DOI] [PubMed] [Google Scholar]
  35. Jeevakumar V, Kroener S. 2016. Ketamine administration during the second postnatal week alters synaptic properties of fast-spiking interneurons in the medial prefrontal cortex of adult mice. Cereb Cortex. 26:1117–1129. [DOI] [PubMed] [Google Scholar]
  36. Kim H, Gibboni R, Kirkhart C, Bao S. 2013. Impaired critical period plasticity in primary auditory cortex of fragile X model mice. J Neurosci. 33:15686–15692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kraus HJ, Aulbach-Kraus K. 1981. Morphological changes in the cochlea of the mouse after the onset of hearing. Hear Res. 4:89–102. [DOI] [PubMed] [Google Scholar]
  38. La Fata G, Gärtner A, Domínguez-Iturza N, Dresselaers T, Dawitz J, Poorthuis RB, Averna M, Himmelreich U, Meredith RM, Achsel T, et al. . 2014. FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. Nature Neurosci. 17:1693–1700. [DOI] [PubMed] [Google Scholar]
  39. Largo RH, Schinzel A. 1985. Developmental and behavioural disturbances in 13 boys with fragile X syndrome. Eur J Pediatr. 143:269–275. [DOI] [PubMed] [Google Scholar]
  40. Lensjø KK, Lepperød ME, Dick G, Hafting T, Fyhn M. 2017. Removal of perineuronal nets unlocks juvenile plasticity through network mechanisms of decreased inhibition and increased gamma activity. J Neurosci. 37:1269–1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Li LY, Ji XY, Liang F, Li YT, Xiao Z, Tao HW, Zhang LI. 2014. A feedforward inhibitory circuit mediates lateral refinement of sensory representation in upper layer 2/3 of mouse primary auditory cortex. J Neurosci. 34:13670–13683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Liu H, Gao P-F, Xu H-W, Liu M-M, Yu T, Yao J-P, Yin Z-Q. 2013. Perineuronal nets increase inhibitory GABAergic currents during the critical period in rats. Intl J Ophthalmol. 6:120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lovelace JW, Wen TH, Reinhard S, Hsu MS, Sidhu H, Ethell IM, Binder DK, Razak KA. 2016. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome. Neurobiol Dis. 89:126–135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Martin Del Campo HN, Measor KR, Razak KA. 2012. Parvalbumin immunoreactivity in the auditory cortex of a mouse model of presbycusis. Hear Res. 294:31–39. [DOI] [PubMed] [Google Scholar]
  45. McNaughton CH, Moon J, Strawderman MS, Maclean KN, Evans J, Strupp BJ. 2008. Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav Neurosci. 122:293. [DOI] [PubMed] [Google Scholar]
  46. McRae PA, Rocco MM, Kelly G, Brumberg JC, Matthews RT. 2007. Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J Neurosci. 27:5405–5413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, Tassone F, Nietzel K, Stackhouse T, Hagerman RJ. 1999. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome. Am J Med Genet. 83:268–279. [PubMed] [Google Scholar]
  48. Morawski M, Brückner MK, Riederer P, Brückner G, Arendt T. 2004. Perineuronal nets potentially protect against oxidative stress. Exp Neurol. 188:309–315. [DOI] [PubMed] [Google Scholar]
  49. Morawski M, Reinert T, Meyer-Klaucke W, Wagner FE, Tröger W, Reinert A, Jäger C, Brücker G, Arendt T. 2015. Ion exchanger in the brain: Quantitative analysis of perineuronally fixed anionic binding sites suggests diffusion barriers with ion sorting properties. Sci Rep. 5:16471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Musumeci SA, Hagerman RJ, Ferri R, Bosco P, Bernardina BD, Tassinari CA, de Sarro GB, Elia M. 1999. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia. 40:1092–1099. [DOI] [PubMed] [Google Scholar]
  51. Nagy V, Bozdagi O, Matynia A, Balcerzyk M, Okulski P, Dzwonek J, Costa R, Silva A, Kaczmarek L, Huntley GW. 2006. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci. 26:1923–1934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Natan RG, Briguglio JJ, Mwilambwe-Tshilobo L, Jones SI, Aizenberg M, Goldberg EM, Geffen MN. 2015. Complementary control of sensory adaptation by two types of cortical interneurons. eLife. 4:e09868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Oswald AMM, Reyes AD. 2011. Development of inhibitory timescales in auditory cortex. Cereb Cortex. 21:1351–1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Paluszkiewicz SM, Olmos-Serrano JL, Corbin JG, Huntsman MM. 2011. Impaired inhibitory control of cortical synchronization in fragile X syndrome. J Neurophysiol. 106:2264–2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Paxinos G, Franklin KBJ. 2004. The mouse brain in stereotaxic coordinates. San Diego (CA): Gulf Professional Publishing. [Google Scholar]
  56. Pietropaolo S, Guilleminot A, Martin B, D’Amato FR, Crusio WE. 2011. Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice. PLoS ONE. 6:e17073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L. 2002. Reactivation of ocular dominance plasticity in the adult visual cortex. Science. 298:1248–1251. [DOI] [PubMed] [Google Scholar]
  58. Reinhard SM, Razak KA, Ethell IM. 2015. A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders. Front Cell Neurosci. 9:1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM. 2010. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci. 30:15337–15357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Roberts JE, Hatton DD, Bailey DB. 2001. Development and behavior of male toddlers with fragile X syndrome. J Early Intervention. 24:207–223. [Google Scholar]
  61. Rotschafer S, Razak KA. 2013. Altered auditory processing in a mouse model of fragile X syndrome. Brain Res. 1506:12–24. [DOI] [PubMed] [Google Scholar]
  62. Rubenstein JL, Merzenich MM. 2003. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2:255–2267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Sabaratnam M, Vroegop PG, Gangadharan SK. 2001. Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure. 10:60–63. [DOI] [PubMed] [Google Scholar]
  64. Saffary R, Xie Z. 2011. FMRP regulates the transition from radial glial cells to intermediate progenitor cells during neocortical development. J Neurosci. 31:1427–1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Schiff ML, Reyes AD. 2012. Characterization of thalamocortical responses of regular-spiking and fast-spiking neurons of the mouse auditory cortex in vitro and in silico. J Neurophysiol. 107:1476–1488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Selby L, Zhang C, Sun Q-Q. 2007. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci Lett. 412:227–232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Sidhu H, Dansie LE, Hickmott PW, Ethell DW, Ethell IM. 2014. Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model. J Neurosci. 34:9867–9879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Sinclair D, Oranje B, Razak KA, Siegel SJ, Schmid S. 2017. Sensory processing in autism spectrum disorders and Fragile X syndrome-from the clinic to animal models. Neurosci & Biobehav Rev. 76:235–253 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Sohal VS, Zhang F, Yizhar O, Deisseroth K. 2009. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 459:698–702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Sugiyama S, Di Nardo AA, Aizawa S, Matsuo I, Volovitch M, Prochiantz A, Hensch TK. 2008. Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity. Cell. 134:508–520. [DOI] [PubMed] [Google Scholar]
  71. Sultan KT, Brown KN, Shi SH. 2013. Production and organization of neocortical interneurons. Front Cell Neurosci. 7:221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Tervonen TA, Louhivuroi V, Sun X, Hokkanen ME, Kratochwil CF, Zebryk P, Castrén E, Castrén ML. 2009. Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol Dis. 33:250–259. [DOI] [PubMed] [Google Scholar]
  73. Van der Molen MJW, Van der Molen MW, Ridderinkhof KR, Hamel BCJ, Curfs MLG, Ramakers GJA. 2012. Auditory and visual cortical activity during selective attention in fragile X syndrome: a cascade of processing deficiencies. Clin Neurophysiol. 123:720–729. [DOI] [PubMed] [Google Scholar]
  74. Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, Erickson CA, Byerly MJ, Sweeney JA. 2017. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodev Disord. 9:11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Winer JA, Miller LM, Lee CC, Schreiner CE. 2005. Auditory thalamocortical transformation: structure and function. Trends Neurosci. 28:255–263. [DOI] [PubMed] [Google Scholar]
  76. Wisniewski KE, Segan SM, Miezejeski CM, Sersen EA, Rudelli RD. 1991. The Fra (X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet. 38:476–480. [DOI] [PubMed] [Google Scholar]
  77. Wlodarczyk J, Mukhina I, Kaczmarek L, Dityatev A. 2011. Extracellular matrix molecules, their receptors, and secreted proteases in synaptic plasticity. Dev Neurobiol. 71:1040–1053. [DOI] [PubMed] [Google Scholar]
  78. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, Holman K, Mulley S, Warren T, Schlessinger D, et al. . 1991. Fragile X genotype characterized by an unstable region of DNA. Science. 252:1179–1181. [DOI] [PubMed] [Google Scholar]
  79. Zhang Y, Bonnan A, Bony G, Ferezou I, Pietropaolo S, Ginger M, Sans N, Rossier J, Oostra B, LeMasson G, et al. . 2014. Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1-/y mice. Nat Neurosci. 17:1701–1709. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data

Articles from Cerebral Cortex (New York, NY) are provided here courtesy of Oxford University Press

RESOURCES